Pharmaceutical innovation succeeds every day, yet patient access too often does not.
Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.
In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry’s most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.
Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.
For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches.
"Sinopsis" puede pertenecer a otra edición de este libro.
Librería: BargainBookStores, Grand Rapids, MI, Estados Unidos de America
Paperback or Softback. Condición: New. Designing Innovation Around Patient Access and Responsibility: Why Early Decisions Determine Who Gets Treated. Book. Nº de ref. del artículo: BBS-9781835569870
Cantidad disponible: 5 disponibles
Librería: California Books, Miami, FL, Estados Unidos de America
Condición: New. Nº de ref. del artículo: I-9781835569870
Cantidad disponible: Más de 20 disponibles
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Paperback. Condición: new. Paperback. Pharmaceutical innovation succeeds every day, yet patient access too often does not.Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9781835569870
Cantidad disponible: 1 disponibles
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9781835569870
Cantidad disponible: Más de 20 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9781835569870
Cantidad disponible: Más de 20 disponibles
Librería: Majestic Books, Hounslow, Reino Unido
Condición: New. Print on Demand. Nº de ref. del artículo: 408457364
Cantidad disponible: 4 disponibles
Librería: Books Puddle, Woodside, NY, Estados Unidos de America
Condición: New. Print on Demand. Nº de ref. del artículo: 26405745483
Cantidad disponible: 4 disponibles
Librería: Biblios, Frankfurt am main, HESSE, Alemania
Condición: New. PRINT ON DEMAND. Nº de ref. del artículo: 18405745473
Cantidad disponible: 4 disponibles
Librería: Revaluation Books, Exeter, Reino Unido
Paperback. Condición: Brand New. 355 pages. 6.00x0.80x9.00 inches. In Stock. Nº de ref. del artículo: x-1835569870
Cantidad disponible: 2 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmaceutical innovation succeeds every day, yet patient access too often does not.Regulatory approval is frequently treated as the finish line, but it only grants permission to market a therapy and does not guarantee that a single patient will receive it, because between approval and adoption lies a complex reality shaped by evidence, affordability, policy, and trust.In Designing Pharmaceutical Innovation Around Patient Access and Responsibility, Tony Toks Akiwumi challenges the industry's most persistent assumption that good science naturally finds its way to patients, drawing on real world experience across development, market access, and policy to show how early decisions in trial design, evidence generation, pricing, and stakeholder engagement quietly determine who gets treated and who does not.Introducing practical frameworks such as the Access Equation, the New Value Triangle, and the Access Maturity Matrix, the book equips organisations to move from approval first thinking to access first design, using case studies, leadership tools, and candid reflection to demonstrate how innovation can be built for adoption rather than hope.For leaders in pharma, biotech, policy, and healthcare, this is both a strategic guide and a moral argument, grounded in a simple truth: the real measure of innovation is not what is approved, but who it ultimately reaches. Nº de ref. del artículo: 9781835569870
Cantidad disponible: 2 disponibles